Abeona Therapeutics

Entity > Corporation > US > New York City New York > Abeona Therapeutics

About Abeona Therapeutics

Abeona Therapeutics Inc. is a Delaware-based clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases.

Abeona Therapeutics Inc.’s Clinical Programs: Abeona Therapeutics' lead clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa ("RDEB"), which is currently in the pivotal Phase 3 VIITAL™clinical trial. Following a comprehensive portfolio review in early 2022, the Company has decided to focus its research and development resources on the VIITAL™ readout while actively seeking a potential commercialization partner for EB-101 to reduce operating costs and extend cash runway. As part of this portfolio prioritization, the Company has intensified its efforts to form a strategic partnership to acquire the development activities for the AAV-based gene therapy ABO -102 for Sanfilippo syndrome type A ("MPS IIIA") and discontinued the development of AAV-based gene therapy ABO -101 for Sanfilippo syndrome type B ("MPS IIIB").

Abeona Therapeutics Inc. was Founded in 2015: Abeona Therapeutics Inc. was Founded in 2015 with headquarters located at New York, United States. At present, Vishwas Seshadri, Ph.D., M.B.A. serves as Chief Executive Officer and Director, Brian Kevany, Ph.D. as Vice President and Chief Technical Officer and Head of Research, and Joseph Vazzano as Chief Financial Officer.

Abeona Therapeutics Inc.’s Patient Advocacy and Community Engagements: The company supports its patient communities by advocating for them. This includes participating in special events, patient conferences and industry forums that raise awareness of the diseases the company seeks to treat, educate the public and inspire others to advocate for patients.

Abeona Therapeutics Inc.’s Mission: Working together to deliver cell and gene therapies for people impacted by serious diseases. Our strategy to harness the promise of genetic medicine to transform the lives of patients is inspired by our vision, to realize a world where cure is the new standard of care.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Abeona Therapeutics

Company Attribute Value
Address StreetAddress: 1330 Avenue of the Americas Fl 33, AddressLocality: New York City, AddressRegion: New York, PostalCode: 10019, AddressCountry: United States
Founding Date 2013
Name Abeona Therapeutics
Number Of Employees 90
Revenue $3,346,000 USD
Ticker Symbol NASDAQ: ABEO
Url abeonatherapeutics
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google
Wikidata wikidata

Abeona Therapeutics

us

New York City, US
23 Jun 2024

New York City, US
23 Jun 2024

Abeona Therapeutics

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.abeonatherapeutics.com/
Abeona Therapeutics Inc. (ABEO)
Working together to deliver cell and gene therapies for people impacted by serious diseases · Our inspiration · Pipeline · Manufacturing at The Elisa Linton ...
https://finance.yahoo.com › quote › ABEO
Abeona Therapeutics Inc. (ABEO) Stock Price, News, ...
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
https://www.linkedin.com/company/abeonatherapeutics
Abeona Therapeutics
Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine.
https://www.fiercepharma.com › pharma › another-dela...
FDA rejects Abeona' Therapeutics' topical gene therapy pz- ...
Apr 23, 2024 — The FDA has rejected Abeona Therapeutics' gene therapy pz-cel, specifying chemistry, manufacturing and controls (CMC) issues that must be ...
https://www.marketwatch.com › ... › United States
Abeona Therapeutics Inc. Stock Quote (U.S.: Nasdaq)
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare ...
https://www.bloomberg.com › quote › ABEO:US
ABEO: Abeona Therapeutics Inc Stock Price Quote
Abeona Therapeutics Inc. is a leading clinical-stage biopharmaceutical company. The Company develops novel gene therapies for life-threatening rare diseases.
https://www.nasdaq.com › Market Activity › Stocks
Abeona Therapeutics Inc. Common Stock (ABEO)
Discover real-time Abeona Therapeutics Inc. Common Stock (ABEO) stock prices, quotes, historical data, news, and Insights for informed trading and ...
Related Searches
Related Searches
Abeona therapeutics news
Abeona Therapeutics buyout
Abeona therapeutics fda approval
Knowledge Panel
Knowledge Panel

Abeona Therapeutics (Biotech company)

abeonatherapeutics.com/

  • Stock price : ABEO (NASDAQ) $4.58 +0.06 (+1.33%)Jun 21, 4:00 PM EDT - Disclaimer
  • Headquarters : Cleveland, OH
  • Founded : 1974

Related Entities Abeona Therapeutics

Entity Home Kalicube Pro Entity Page
Abeona Therapeutics Entity Home Abeona Therapeutics on Kalicube

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193755